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Catheter-related bacteremia is a major complication in patients with long-term surgically
implanted central venous catheters, which are difficult and expensive to remove.
Conventional treatment fails in a significant number of cases, resulting in removal of
the device. The antibiotic-lock technique involves instilling a high concentration of
antibiotic into the catheter lumen, and allowing it to remain for a period of time. Results
of several open studies, mainly involving patients receiving home parenteral nutrition,
indicate that this method may be regarded as an alternative to the conservative treatment
of noncomplicated intraluminal catheter-related bacteremia, in which infection may be
treated without catheter removal. However, many questions about this therapeutic
method remain to be resolved, including appropriate concentration of antibiotics,
duration of treatment, and whether or not concomitant systemic antibiotic therapy is
necessary. Prospective studies comparing the antibiotic-lock technique with conven-
tional treatment are needed.
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I N T R O D U C T I O N
Intravascular catheters have become essential
tools for the adequate management of patients
in modern medical practice [1]. They are used
for the administration of intravenous fluids, med-
ications, blood products, and parenteral nutrition
fluids, to provide hemodialysis, and to monitor the
hemodynamic status of patients [2]. It is estimated
that more than 150 million intravascular catheters
are purchased annually by clinics and hospitals in
the USA [3]. The majority of these devices are
peripheral venous catheters, but more than 5 mil-
lion central venous catheters are inserted each
year. In particular, the use of tunnelled Broviac–
Hickman-type catheters and totally implantable
venous access devices (ports), has increased
notably over the past years (Figure 1). As a result
of the use of these devices, infection has become a
significant clinical problem [4–12]. Currently,
catheter-related bacteremia is a major cause of
patient morbidity, a reason for premature catheter
removal, and an explanation for the increase in
cost and use of resources [13–19]. The appropriate
management of catheter-related infections has,
therefore, become a major challenge for physicians.
This review will focus on the usefulness of the
antibiotic-lock technique for therapy of ‘highly
needed’ infected catheters.
C O N V E N T I O N A L M A N A G E M E N T O F
C A T H E T E R - R E L A T E D I N F E C T I O N
The management of catheter-related infection
involves decisions regarding the necessity of the
removal of the catheter and the administration of
antibiotics. The determination of whether the
catheter should be removed or remain in place
should take into consideration at least three fac-
tors: the type of catheter, the type and microbiol-
ogy of the infection, and the status of the patient
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[20,21]. Thus, for peripheral catheters prompt
removal remains the mainstay of therapy [22].
On the other hand, although catheter removal is
frequently viewed as the only appropriate treat-
ment, this procedure raises important practical
problems in ‘highly needed’ catheters, such as
Broviac–Hickman-type catheters and totally impl-
antable venous access devices (ports) [22–24].
These catheters are expensive and they must be
implanted and withdrawn in the operating thea-
ter. Moreover, these devices are used in patients
who are frequently debilitated and with no other
available vascular access, such as patients receiv-
ing long-term parenteral nutrition [4,5], patients
requiring dialysis [25,26], as well as patients with
acquired immune deficiency syndrome (AIDS) or
cancer patients [6,12]. In these clinical settings, an
attempt to treat catheter-related bacteremia is
often carried out with a seven to 21-day course
of systemic antibiotics administered through the
catheter without catheter removal. However, this
approach fails in approximately 30% of treat-
ments, resulting in removal of the device
[10,11,27–30]. These failures can be explained, at
least partially, by the inability of most antibiotics to
kill bacteria growing in a biofilm in therapeutically
achievable concentrations [31,32]. In fact, it is well
known that many micro-organisms in the presence
of biomaterial will adhere tenaciously to its inert
surface [33]. Moreover, several studies have
demonstrated that once a micro-organism adheres
to the surface of a catheter, its antimicrobial sus-
ceptibility is altered and it becomes resistant, or at
least tolerant [34,35]. In addition, biofilm bacteria
are also resistant to host defense agents such as
phagocytes and antibodies. Importantly, recent
investigations have shown that antibiotic concen-
trations must be 100–1000 times greater to kill
biofilm bacteria than to kill bacteria in solution
[35–37]. To overcome these problems, and taking
into consideration the fact that the majority of
infections in tunnelled catheters originated in
the catheter hub and spread intralumenally, an
antibiotic-lock technique has been developed for
treatment of catheter-related infection.
A N T I B I O T I C - L O C K T E C H N I Q U E
The antibiotic-lock technique consists of filling the
catheter lumen with an antibiotic solution and
allowing it to dwell for a period of time, in order
to sterilize the device [38] (Figure 2). With this
method, a high local concentration of an appro-
priate antibiotic can be applied in the catheter
lumen while avoiding systemic toxicity and the
need to monitor serum drug levels [39,40]. In
addition, since the catheter is closed, there is no
risk of distant spread of micro-organisms, as may
occur with continuous perfusion of antibiotics
through the infected catheter. The antibiotic-lock
technique is particularly appealing for treatment
of noncomplicated (absence of hypotension or
organ hypoperfusion, septic thrombosis and septic
emboli) central venous catheter-related infection
of intralumenal origin. Table 1 summarizes the
possible advantages and disadvantages of this
therapeutic approach.
The technique was initially designed in the late
1980s by Messing et al. [38]. It was derived from
the practice of the heparin-lock technique, which
had been developed earlier in conjunction with the
common cyclic 12-h rhythm delivery for patients
Figure 1 Surgically implantable central venous catheters:
Broviac–Hickman catheters and a totally implantable
venous access device (port).
Figure 2 Antibiotic-lock technique.
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receiving parenteral nutrition at home. The inves-
tigators hypothesized that the antibiotic-lock tech-
nique could cure intraluminal catheter-related
infection on the grounds that a high concentration
of antibiotic would be delivered into the catheter
lumen and it would be bactericidal during the
administration time [38,41]. Messing et al. used
a 2-mL saline antibiotic-lock with either 1–2 mg/
mL of vancomycin or 1.5–3 mg/mL of amikacin
[38]. They calculated that vancomycin and amika-
cin levels in situ would be 40–80-fold and 60–120-
fold higher, respectively, with antibiotic-lock than
the peak serum inhibitory concentrations achieved
by conventional dosage of the corresponding sys-
temic antibiotic [41]. Messing et al. were initially
concerned by a possible physicochemical incom-
patibility between the antibiotics and heparin [38].
However, several studies have since demonstrated
the stability in the presence of heparin of those
antibiotics most commonly used for antibiotic-lock
treatment of catheter-related infection [42–45].
In a recent study, Benoit et al. [46] determined
the concentration of antibiotic in the intraluminal
fluid from catheters of patients treated with the
antibiotic-lock technique using vancomycin at a
concentration of 5 mg/mL for 8–12 h. This study
showed that the concentration of vancomycin was
initially about 5 mg/mL and it remained at
approximately 3 mg/mL throughout the period
of time that the solution was locked in the catheter.
Gaillard et al. [31], using a quantitative in vitro
model simulating clinical conditions, studied the
efficacy of conventional and nonconventional 3-
day therapies involving vancomycin for treating
the internal surface of catheters colonized with a
slime-producing strain of Staphylococcus epidermi-
dis. When infused through the catheter for 1 h
every 8 h at a dose of 450 mg (daily dose recom-
mended for a 10-kg child), vancomycin alone
reduced bacterial colonization but failed to ster-
ilize the devices. Vancomycin was found to be
more active in combination with netilmicin
(25 mg for 1 h every 8 h), rifampin (150 mg for
90 min every 12 h), or fosfomycin (500 mg for 4 h
every 6 h), but the catheters were inconsistently
decontaminated after 3 days of treatment. More-
over, the investigators studied two nonconven-
tional modes of antibiotic administration, such
as the continuous infusion and the antibiotic-lock
technique, for their capacity to ensure high levels
of vancomycin in the catheter lumen over a pro-
longed time. They found that vancomycin infused
continuously through the catheter at a daily dose
of 450 mg had the same poor sterilizing effect as
vancomycin administered intermittently. Conver-
sely, catheters were totally decontaminated when
2.5 mg of vancomycin in a volume of 0.5 mL was
injected twice daily into noninfused catheters,
confirming that the antibiotic-lock technique is
an interesting approach to sterilizing the internal
surfaces of catheters colonized with staphylococci.
More recently, Andris et al. [47] designed an in
vitro model to evaluate the efficacy of instilled
antimicrobial agents by the antibiotic-lock techni-
que to reduce or eliminate intraluminal microbial
colonization. They used reference and clinical
test strains of Staphylococcus aureus, S. epidermidis
(biofilm-producing and nonproducing strains),
Klebsiella pneumoniae, Enterobacter aerogenes, Can-
dida albicans and Candida tropicalis to inoculate
the intraluminal surface of silicone catheter seg-
ments. In this study [47], a significant decrease in
staphylococcal intraluminal colonization after
instillation of nafcillin, ceftriaxone, gentamicin
and vancomycin was demonstrated (P< 0.001).
Moreover, aztreonam, ceftriaxone and gentamycin
completely eliminated Gram-negative catheter
colonization (P< 0.001), yeasts were eradicated
from the internal catheter surface after treatment
with amphotericin B, and fluconazole significantly
decreased intraluminal colonization (P< 0.001).
The study documented, by bioassay, that the anti-
microbial agents tested were all stable and active
over a 12-h time span.
C L I N I C A L E X P E R I E N C E W I T H T H E
A N T I B I O T I C - L O C K T E C H N I Q U E
The most significant clinical experiences with the
antibiotic-lock technique for therapy of ‘highly
needed’ infected catheters are shown in Table 2.
Table 1 Advantages and disadvantages of the antibiotic-
lock technique for treatment of catheter-related bacteremia
Advantages Disadvantages
High concentration of
antibiotic
Lack of activity against organ-
isms at distant sites
Lack of toxicity Possible delay in curing the in-
fection if the antibiotic-lock fails
Low cost
Ease of administration
Home therapy
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The majority of reported information deals with
patients receiving long-term parenteral nutrition
[38,46,48–50]. Nevertheless, some studies have
also been performed in other settings such as
patients requiring dialysis, as well as in AIDS
and cancer patients [26,51–53].
Home parenteral nutrition
Messing et al. [38] were the first to describe the use
of the antibiotic-lock technique for treatment of
catheter-related sepsis. Their study involved home
parenteral nutrition patients with surgically
implanted silicon catheters. During a cumulated
survey of 286 months, covering 11 patients receiv-
ing nocturnal, cyclic home parenteral nutrition,
they documented 24 cases of catheter-related sep-
sis. No case was associated with the focus of the
infection being at the skin entry site or at the
subcutaneous tunnel of the catheters. In their
study, an attempt was made to control sepsis
without catheter removal. The first two cases of
catheter sepsis were conventionally treated with
systemic antibiotics for 3 weeks, which meant a 1-
month hospital admission each time. Alterna-
tively, Messing et al. [38] used an antibiotic-lock
technique which consisted of intraluminal admin-
istration of a concentrated antibiotic solution for
12-h periods. The antibiotics administered were
amikacin, minocyclen, or vancomycin at concen-
trations of 1.5, 0.2 and 1.0 mg/mL, respectively.
Two milliliters of antibiotic solution was injected
through the luer-lock cap of the catheter. After
identification of bacterial strains by blood cultures,
in 11 cases the antibiotic-lock technique was
applied alone at home for a mean of 16 days,
while 11 other patients received systemic in-
hospital treatment for 3 days, followed by home
antibiotic-lock therapy for 12 days. Failure of treat-
ment, leading to catheter removal, was observed
once in each group (9%), and was due to secondary
Candida spp. catheter sepsis.
In a second study dealing with gastroenterolo-
gical patients receiving long-term cyclic nocturnal
home parenteral nutrition [48], the same investi-
gators treated 27 cases of catheter-related sepsis to
confirm their preliminary results. In this study, 19
episodes were caused by coagulase-negative sta-
phylococci. Patients were treated with a daily
2-mL injection of antibiotic solution, mainly ami-
kacin, locked for 12 h per day within the infected
catheter for a mean of 15 days. In seven cases, an
average of 3 days of systemic antibiotic therapy
was given in addition to the antibiotic-lock ther-
apy. Control of catheter-related sepsis was
achieved in 93% of the 27 episodes, and parenteral
nutrition was resumed using the same catheter,
with only one episode of recurrent sepsis.
In 1994, Johnson et al. [49]. described their
experience with the use of the antibiotic-lock tech-
nique for treatment of catheter-related sepsis in 12
children receiving home parenteral nutrition. In
this study, treatment consisted of intraluminal
administration of 2 mg/mL of antibiotic solution
12 h per day for 10–14 days. They observed only
two cases of therapeutic failure occurring in
patients using a Port-A-Cath.
In a more recent study [46], Benoit et al. carried
out an open, uncontrolled, prospective evaluation
of intraluminal antibiotic therapy for bloodstream
infections arising from subcutaneously tunneled
central venous catheters in patients receiving
home parenteral nutrition. Intraluminal anti-
biotics were prepared as a 3-mL solution that
was instilled daily into the catheter lumen and
was allowed to dwell for 8–12 h. The antibiotics
Table 2 Clinical experience with the use of the antibiotic-lock technique for therapy of ‘highly needed’ infected catheters
Reference Patient population
No. of episodes
treated
No. of episodes
cured
[38] Messing et al. (1988) Parenteral nutrition 22 20
[48] Messing et al. (1990) Parenteral nutrition 27 25
[49] Johnson et al. (1994) Parenteral nutrition 12 10
[46] Benoit et al. (1995) Parenteral nutrition 9 7
[50] Krzywda et al. (1995) Parenteral nutrition 22 14
[26] Capdevila et al. (1993) Dialysis 13 13
[51] Capdevila et al. (1994) AIDS 12 12
[52] Longuet et al. (1995) AIDS 14 6
Cancer
[53] Domingo et al. (1999) AIDS 27 22
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used were vancomycin, gentamycin, or amphoter-
icin B, depending on the causative organism of the
infection, at concentrations of 5, 5, and 2.5 mg/mL,
respectively. Seven bacterial infections were suc-
cessfully treated with intralumenal antibiotics
(mean duration, 8.6 days), sometimes accompa-
nied by systemic antibiotics (mean duration,
2.1 days). Two infections caused by Candida spp.
were treated with intralumenal amphotericin B
and failed to respond. Fungal infection was sup-
pressed during treatment, but it later manifested,
as confirmed by pulse-field DNA electrophoresis-
typing of bloodstream isolates.
In an open study [50], Krzywda et al. evaluated
the usefulness of an antibiotic-lock technique for
treatment of Hickman catheter sepsis. The techni-
que consisted of instillation of 3 mL of a highly
concentrated antimicrobial agent into the catheter
lumen, where it remained for 12 h. The length of
therapy ranged from 5 to 17 days (mean, 8 days).
The investigators treated 22 episodes of catheter-
related sepsis occurring in six patients over a 5-
year period, the majority of whom were receiving
home parenteral nutrition. In five patients, the use
of the antibiotic-lock technique was successful in
11 of 12 episodes. Staphylococcus epidermidis was
the predominant organism recovered from these
patients (nine of 12 episodes). One therapeutic
failure was associated with Rhodotorula catheter
sepsis unresponsive to amphotericin B, resulting
in catheter removal. A sixth patient receiving
home parenteral nutrition, who had four abdom-
inal ‘ostomies’ (gastrostomy, jejunostomy, ileost-
omy and mucous fistula), developed 10 episodes
of catheter-related sepsis over a 2-year period, and
only three of these were treated successfully by
antibiotic-lock technique.
Dialysis patients
The clinical experience using the antibiotic-lock
technique for treatment of catheter-related sepsis
in dialysis patients is limited to the work of Cap-
devila et al. [26], who prospectively studied 36
chronic renal failure patients with double-lumen
catheters inserted into the internal jugular vein. In
their study, when catheter-related sepsis was sus-
pected a quantitative blood culture was obtained
simultaneously from the catheter and from a per-
ipheral vein. Patients were empirically given sys-
temic intravenous vancomycin as antimicrobial
therapy while the central line remained in place
and dialysis was continued using it. If bacterial
colonies in the catheter blood specimen were four-
fold greater than identical bacterial colonies in the
peripheral blood specimen, the test was consid-
ered indicative of catheter sepsis. Overall, 11
patients had 13 episodes of catheter-related sepsis;
S. epidermidis and Pseudomonas aeruginosa account-
ed for 77% of the strains isolated. Vancomycin or
ciprofloxacin was administered in a 4-h continu-
ous infusion, at a concentration of 100 mg/mL in
5% sodium heparin, in each catheter lumen
between two dialysis sessions. Antibiotics were
given for 15 days and all episodes of catheter-
related sepsis were successfully treated without
catheter removal, yielding negative results on fol-
low-up quantitative cultures. Interestingly, in
eight patients the catheters were removed later
because they were no longer needed and were
found to have a negative tip culture.
AIDS and cancer patients
There is some clinical experience with the use of
the antibiotic-lock technique for the treatment of
catheter-related infection in human immunodefi-
ciency virus (HIV)-infected patients and much less
data regarding cancer patients [51–53].
Capdevila et al. [51] prospectively studied 36
HIV-infected patients who required long-term
venous catheterization for cytomegalovirus sec-
ondary prophylaxis in order to determine the
efficacy of the antibiotic-lock technique, plus
replacement of the catheter for treatment of cathe-
ter-related infection. Overall, they observed 15
episodes of infection (0.25 episodes for 100 days
per patient), mostly caused by coagulase-negative
staphylococci. Patients were given vancomycin or
ciprofloxacin for 15 days along with systemic
antibiotics when sepsis was documented. The
antibiotic-lock technique was performed, deliver-
ing 1 mL antibiotic solution through the catheter
at a concentration of 50 mg/L, and leaving the
catheter closed during the treatment. Three pa-
tients were excluded for conservative manage-
ment because of septic shock, subcutaneous
infection and catheter thrombosis. The remaining
12 episodes of catheter-related infection were
cured with the device maintained in place.
Longuet et al. [52] investigated the efficacy of an
antibiotic-lock in combination with systemic anti-
biotic therapy in catheter-related bacteremia invol-
ving HIV or oncology patients with Port-A-Cath or
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Hickman catheters. The diagnosis was performed
by quantitative blood cultures obtained simulta-
neously from the catheter and from a peripheral
vein. They treated 14 episodes of catheter-related
bacteremia, eight of them caused by coagulase-
negative staphylococci. The antibiotic-lock con-
sisted of intraluminal delivery of vancomycin,
teicoplanin, or amikacin at a concentration of
5 mg/mL. In this study, failure was documented
in eight of 14 cases, with persistent fever and/or
positive cultures within 8 days of treatment. Cure
was achieved in six patients, who yielded culture-
negative samples; all the catheters later removed
from these patients for other reasons were sterile.
In a recent study [53], Domingo et al. evaluated
the usefulness of an antibiotic-lock technique for
treatment of Port-A-Cath infection in patients with
AIDS. They studied 68 consecutive patients with
AIDS requiring 79 such devices for long-term use,
mainly because of cytomegalovirus infection,
inserted over a 5-year period. Device-related infec-
tion occurred in 33 cases, and the predominant
causative organisms were Gram-positive cocci.
Twenty-seven episodes of infection were treated
with the antibiotic-lock technique, along with sys-
temic antibiotics in cases of bacteremia. Vancomy-
cin or amikacin was administered at a
concentration of 1 mg/mL. The solution was used
to refill the Port-A-Cath chamber daily for 5 days.
The remaining six cases of device-related infection
were treated with sytemic antibiotic therapy alone.
The percentage of patients in whom the catheter
had to be removed was significantly higher in
those cases treated with isolated systemic antibio-
tic therapy than in cases treated with the antibiotic-
lock technique: 83% (five of six patients) versus
19% (5 of 27 patients) (P¼ 0.008).
C O N S I D E R A T I O N S A B O U T T H E U S E
O F T H E A N T I B I O T I C - L O C K
T E C H N I Q U E
As reviewed above, the results of several open
studies indicate that the antibiotic-lock technique
may be considered as an alternative to the con-
servative treatment of ‘highly needed’ infected
catheters. Overall, therapeutic success with cathe-
ter salvage was obtained in 129 (82%) of the 158
episodes treated in these studies (Table 2). It is
important to point out, nevertheless, that the anti-
biotic-lock technique must be avoided for treat-
ment of complicated catheter-related infections, as
well as in cases with evidence of extraluminal
infection (inflammation over the tunnel or exit site
or pocket of a totally implanted port). Moreover, it
should be noted that most failures with the use of
the antibiotic lock technique have been observed
in cases of catheter-related fungal infection. On the
other hand, treatment of patients with S. aureus
catheter-related bacteremia should include a full
course of systemic parenteral therapy along with
the antibiotic lock technique.
To date, on the basis of the available evidence,
there are several questions that remain unresolved
about the use of the antibiotic-lock technique
(Table 3). In particular, the usefulness of different
types of antibiotics, their optimum concentration,
as well the duration of treatment and the necessity
of concurrent systemic treatment should be
defined [54]. The major criticism regarding this
method is that no randomized, double-blind
study comparing the antibiotic-lock technique
with conventional treatment has been carried
out. Therefore, prospective trials with an appro-
priate design involving a sufficient number of
patients are needed.
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